
Novartis provides updates on safety of Beovu (brolucizumab)
This global website will be updated regularly in order to provide the latest information and guidance for Health Care Professionals
Updated: April 01, 2021

New publication
The findings of the SRC review of the HAWK & HARRIER trials have been published in Ophthalmology
Read more
Beovu real-world evidence
Read moreA retrospective, real-world evidence analysis provides information regarding intraocular inflammation and/or retinal vascular occlusion and Beovu use